Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
A simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) <em>ex vivo</em>. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the bio...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/5/5/405 |
_version_ | 1818559771382382592 |
---|---|
author | Teruyuki Nagamune Satoshi Takamori Satoshi Yamaguchi Yoichiro Sugimoto Urara Tomita |
author_facet | Teruyuki Nagamune Satoshi Takamori Satoshi Yamaguchi Yoichiro Sugimoto Urara Tomita |
author_sort | Teruyuki Nagamune |
collection | DOAJ |
description | A simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) <em>ex vivo</em>. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the biocompatible anchor for the membrane (BAM), arbitrary IgG could be incorporated into the cell membrane. In particular, when IgG-BAM conjugates were prepared at the optimal molar ratio of IgG to BAM (1 to 20), almost all cells were efficiently modified with IgG by treatment with IgG-BAM. This simple method was successfully applied to four types of mammalian cells. Furthermore, treatment of ATCs with the IgG-BAM conjugate increased the phagocytosis ratio of ATCs by DCs two-fold when compared to no treatment. This phagocytosis-enhancing effect was nearly identical to treatment with a tumor-specific IgG. Thus, without employing the tumor-specific IgG, which is difficult to obtain for any tumor cells and is expensive, the present method could opsonize ATC with the use of arbitrary IgG. The results strongly indicate that IgG-BAM treatment represents a promising method for opsonizing ATC with human serum IgG, and that this approach will lead to objective clinical responses in DC vaccines. |
first_indexed | 2024-12-14T00:29:52Z |
format | Article |
id | doaj.art-5044990bbd734e739591722ff2e8a24b |
institution | Directory Open Access Journal |
issn | 1424-8247 |
language | English |
last_indexed | 2024-12-14T00:29:52Z |
publishDate | 2012-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceuticals |
spelling | doaj.art-5044990bbd734e739591722ff2e8a24b2022-12-21T23:24:53ZengMDPI AGPharmaceuticals1424-82472012-04-015540541610.3390/ph5050405Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer CellsTeruyuki NagamuneSatoshi TakamoriSatoshi YamaguchiYoichiro SugimotoUrara TomitaA simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) <em>ex vivo</em>. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the biocompatible anchor for the membrane (BAM), arbitrary IgG could be incorporated into the cell membrane. In particular, when IgG-BAM conjugates were prepared at the optimal molar ratio of IgG to BAM (1 to 20), almost all cells were efficiently modified with IgG by treatment with IgG-BAM. This simple method was successfully applied to four types of mammalian cells. Furthermore, treatment of ATCs with the IgG-BAM conjugate increased the phagocytosis ratio of ATCs by DCs two-fold when compared to no treatment. This phagocytosis-enhancing effect was nearly identical to treatment with a tumor-specific IgG. Thus, without employing the tumor-specific IgG, which is difficult to obtain for any tumor cells and is expensive, the present method could opsonize ATC with the use of arbitrary IgG. The results strongly indicate that IgG-BAM treatment represents a promising method for opsonizing ATC with human serum IgG, and that this approach will lead to objective clinical responses in DC vaccines.http://www.mdpi.com/1424-8247/5/5/405antibody conjugatesdendritic cell vaccineantibody-dependent cell phagocytosispoly(ethylene glycol)-lipid |
spellingShingle | Teruyuki Nagamune Satoshi Takamori Satoshi Yamaguchi Yoichiro Sugimoto Urara Tomita Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells Pharmaceuticals antibody conjugates dendritic cell vaccine antibody-dependent cell phagocytosis poly(ethylene glycol)-lipid |
title | Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells |
title_full | Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells |
title_fullStr | Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells |
title_full_unstemmed | Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells |
title_short | Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells |
title_sort | poly ethylene glycol lipid conjugated antibodies enhance dendritic cell phagocytosis of apoptotic cancer cells |
topic | antibody conjugates dendritic cell vaccine antibody-dependent cell phagocytosis poly(ethylene glycol)-lipid |
url | http://www.mdpi.com/1424-8247/5/5/405 |
work_keys_str_mv | AT teruyukinagamune polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells AT satoshitakamori polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells AT satoshiyamaguchi polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells AT yoichirosugimoto polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells AT uraratomita polyethyleneglycollipidconjugatedantibodiesenhancedendriticcellphagocytosisofapoptoticcancercells |